Nong-Hua Lu Selected Research

Nong-Hua Lu Research Topics

Disease

21	Infections 02/2024 - 03/2007
10	Stomach Neoplasms (Stomach Cancer) 01/2022 - 02/2013
9	Neoplasms (Cancer) 01/2019 - 11/2012
7	Carcinogenesis 12/2021 - 06/2012
4	Acute Necrotizing Pancreatitis 06/2020 - 01/2017
3	Necrosis 04/2024 - 06/2020
3	Pancreatitis 01/2022 - 11/2017
3	Metaplasia 12/2021 - 11/2012
3	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2014
2	Inflammation (Inflammations) 04/2024 - 10/2016
2	Pathologic Processes 04/2024 - 10/2013
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2014
2	Gastritis 01/2016 - 02/2013
2	Carcinoma (Carcinomatosis) 10/2013 - 11/2012
1	Edema (Dropsy) 04/2024
1	Gastroesophageal Reflux (GERD) 05/2022
1	Constipation 01/2022
1	Alcoholic Pancreatitis 01/2022
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 05/2020
1	Multiple Organ Failure (MODS) 05/2020
1	Shock 02/2020
1	Renal Insufficiency (Renal Failure) 02/2020
1	Hypoalbuminemia 09/2018
1	Reinfection 01/2017
1	Intestinal Fistula 01/2017
1	Peptic Ulcer (Peptic Ulcers) 01/2016
1	Choledochal Cyst (Choledochal Cysts) 02/2015
1	Hemorrhage 01/2015
1	Ulcer 01/2015
1	Lymphoma (Lymphomas) 12/2014
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 09/2014
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2014
1	Duodenal Ulcer (Curling's Ulcer) 08/2014
1	Type 2 Diabetes Mellitus (MODY) 04/2014
1	Diabetes Mellitus 04/2014
1	Insulin Resistance 04/2014
1	Atherosclerotic Plaque (Atheroma) 01/2014
1	Esophageal Neoplasms (Esophageal Cancer) 01/2014

Drug/Important Bio-Agent (IBA)

6	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 02/2024 - 01/2017
4	Amoxicillin (Wymox)FDA LinkGeneric 02/2024 - 01/2022
4	CytokinesIBA 05/2020 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 01/2015 - 06/2012
3	Proton Pump InhibitorsIBA 05/2022 - 12/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2014
3	CarcinogensIBA 01/2022 - 01/2016
2	BismuthIBA 06/2023 - 01/2017
2	NF-kappa B (NF-kB)IBA 11/2020 - 10/2016
2	S cerevisiae ASC1 proteinIBA 01/2019 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 11/2015 - 04/2014
2	TensinsIBA 01/2014 - 11/2012
2	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2014 - 02/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 10/2013
1	CeruletideIBA 04/2024
1	NLR ProteinsIBA 04/2024
1	PectinsIBA 06/2023
1	Rabeprazole (Aciphex)FDA Link 05/2022
1	PowdersIBA 01/2022
1	BilirubinIBA 01/2022
1	AlbuminsIBA 01/2022
1	activin AIBA 12/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2020
1	CarbohydratesIBA 07/2020
1	AntigensIBA 07/2020
1	CalciumIBA 02/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	IntegrinsIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 10/2018
1	Serum AlbuminIBA 09/2018
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	SuspensionsIBA 01/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2015
1	CholesterolIBA 11/2015
1	Triglycerides (Triacylglycerol)IBA 11/2015
1	Metronidazole (Metric)FDA LinkGeneric 02/2015
1	Clarithromycin (Biaxin)FDA LinkGeneric 02/2015
1	Levofloxacin (Levaquin)FDA Link 02/2015
1	OccludinIBA 01/2015
1	Epidermal Growth Factor (EGF)IBA 01/2015
1	Hematoxylin (Haematoxylon)IBA 01/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2015
1	Inosine Triphosphate (ITP)IBA 09/2014
1	Furazolidone (Furoxone)FDA Link 08/2014
1	Dihydrotachysterol (AT 10)IBA 08/2014
1	Insulin (Novolin)FDA Link 04/2014
1	LipidsIBA 04/2014
1	Indicators and Reagents (Reagents)IBA 01/2014
1	Phosphates (Orthophosphate)IBA 01/2014
1	Phosphatidylethanolamine Binding ProteinIBA 01/2014
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2014
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2014
1	DNA-Activated Protein KinaseIBA 10/2013
1	Ku AutoantigenIBA 10/2013

Therapy/Procedure

12	Therapeutics 02/2024 - 01/2014
1	Patient Readmission 01/2022
1	Debridement 06/2020
1	Catheters 01/2017
1	Drug Therapy (Chemotherapy) 01/2014